4 EYLÜL 2007, SALI

Laboratory Medicine, past, present and future. Jocelyn M.B. Hicks, USA (IFCC president), 3.9 MB

5 EYLÜL 2007, ÇARŞAMBA

Diagnostic guidelines - A service for clinicians and patients. Mathias Mueller, Austria (IFCC Past-President), 7.0 MB

Targeting HDL for the prevention and management of cardiovascular disease. Victor Blaton, Belgium (FESCC President), 952 K

Posterior and intermediate pituitary lobes: Neuroendocrine, clinical and diagnostic implications. Gabor L. Kovacs, Hungary (FESCC Member at Large), 21.4 MB

Regulation of mast-cells' mediators secretion-hope for allergy treatment. Israel Pecht, Israel, 2.8 MB

ANCA-associated vasculitis in ischemic stroke and hepatitis C virus infection. Manole Cojocaru , Romania, 1.3 MB

Clinical proteomics; Discovery of biomarkers in the diagnostic industry. Michael Fountoulakis, Roche-Switzerland, 17.1 MB

Pharmacogenomics; From gene to patient: towards individualized drug therapy. Michael Eichelbaum, Germany, 20.9 MB

DNA Chips; High-resolution array comparative genomic hybridization: Applications and experiences. Fikret Erdoğan, Germany, 5.8 MB

New strategies for prevention of respiratory tract infections. Alexandra Dana Maria Panait. Sunum-1, 88 KB; Sunum-2, 92 KB

Six sigma and lean concept in laboratory medicine. Abdurrahman Coşkun, Turkey, 688 KB

Reference intervals for hematology parameters in Turkey. Yeşim Özarda İlçöl, Turkey, 232 KB

New techniques in order to diminish the necessary number of normal patients' results in the "average of normals method". Petros Karkalousos, Greece, 996 KB

A Simple Method for the Simultaneous Determination of Immunosuppressants in Blood Using LC-MS/MS. Gerard Bondoux, France, 1.8 MB

A simple automated citrate determination method in urine. Berkay Çataloğlu, Turkey, 116 KB

Decreasing Matrix Effect on Diazo Reaction by Changing Sample Volume and Nitrite Concentration in Total and Direct Bilirubin Determinations. Serkan Ahioğlu, Turkey, 416 KB

6 EYLÜL 2007, PERŞEMBE

Target value for inaccuracy and importance of harmonization. Yahya Laleli, Turkey, 3.2 MB

Management of risk in laboratory practice. Ana Stavljenic, Croatia, 128 KB

Rational laboratory diagnostic and possibilities of inadequate analyses application. Danica Popovic-Pribilovic, Montenegro, 124 KB

The initial experiences in auditing of quality management implementation in Slovenia. Pika Mesko Brguljan, Sasa Bratoz , Slovenia, 432 KB

New perspectives in antenatal screening for Down's syndrome. Demetrios Rizos, Greece, 2 MB

The prevalence of beta thalassemia in students screening Lushnja district, Albania. Etleva Refatllari, Albania, 2.6 MB

Prediction of type II diabetes-new diagnostic perspectives. Adlija Jevric-Causevic, Bosnia and Herzegevonia, 1.5 MB

Abdominal obesity, diabetes and cardiovascular risk. Anna Tzontcheva, Bulgaria, 8.9 MB

27 bp insertion/deletion polymorphism in intron 4 of eNOS gene in Turkish patients with Systemic Sclerosis. İncilay Sinici, Turkey, 1.1 MB

A genetic association between Myocardial Infraction (MI) and Interleukin-1 B (+ 3953) gene polymorphism in Turkish population. Ahmet Arman, Turkey, 2.1 MB

Thalassemia mutation type of Hatay-Altinozu region. Murat Tahiroğlu, Turkey, 23.6 MB

Prostate specific antigen gene expression and telomerase in breast cancer patients: relationship to steroid hormone receptors. Nosratollah Zarghami, Iran, 1.4 MB

Decreased plasma apelin is positively correlated with adiponectin in patients with treatment naive type 2 DM. Serkan Tapan, Turkey, 552 KB

Plasma adiponectin and resistin and insulin resistance in women with polycystic ovary syndrome. Mine Yavuz Taşlıpınar, Turkey, 196 KB

Paraoxonase-1 activity in relation to 4-hydroxynonenal and malondialdehyde in chronic renal failure. A. Yeşim Göçmen, Turkey, 4.2 MB

Biomarkers of cardiovascular disease: Evidence based considerations. Svetlana Ignjatovic and Nada Majkic-Singh (BCLF President), Serbia, 1.3 MB

Fifteen Years of BCLF. Stoyan Danev , Bulgaria (BCLF, Member at Large), 3.6 MB